FDA Adverse Event
Injury
Summary report: N
NEUROMARK SYSTEM
MDR report key: 15519624
·
Received September 30, 2022
Report
- Report Number
- 3016813990-2022-00002
- Event Type
- Injury
- Date Received
- September 30, 2022
- Date of Event
- September 3, 2022
- Report Date
- September 22, 2022
- Manufacturer
- NEURENT MEDICAL LTD.
- Product Code
- GEI
- PMA / PMN Number
- K212666
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Additional Manufacturer Narrative · 0
BLEEDING IS A KNOWN POTENTIAL ADVERSE EVENT AND IS DOCUMENTED IN THE DEVICE LABELLING.
Description of Event or Problem · 0
A PATIENT TREATED WITH THE NEUROMARK SYSTEM PRESENTED WITH ACUTE RIGHT SIDED EPISTAXIS 23 DAYS POST PROCEDURE. SPHENOPALATINE ARTERY (SPA) LIGATION WAS PERFORMED. THE ADVERSE EVENT IS RESOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2647832 | NEUROMARK SYSTEM | RADIOFREQUENCY PROBE | GEI | NEURENT MEDICAL LTD. | FS-002-00 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Female | Required Intervention| H |